Osteoporosis in HIV Infected Postmenopausal Women
感染艾滋病毒的绝经后妇女的骨质疏松症
基本信息
- 批准号:8494520
- 负责人:
- 金额:$ 67.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAdverse effectsAffectAfrican AmericanAgeAgingAnti-Retroviral AgentsBiochemicalBiological AssayBiopsyBody mass indexBone DensityBone remodelingCD4 Lymphocyte CountCellular biologyCytochrome P450DataDeteriorationElderlyEnrollmentForearmFractureFundingGrantHIVHIV InfectionsHigh PrevalenceHip region structureHispanicsIncidenceLongitudinal StudiesMetabolismMineralsMinorityNew York CityNucleotidesOsteoblastsOsteoclastsOsteoporosisPeripheralPopulationPostmenopausePrevalenceProtease InhibitorPublic HealthRecruitment ActivityRegimenRequest for ProposalsResolutionReverse Transcriptase InhibitorsRiskRisk FactorsRitonavirSubgroupTechniquesTenofovir disoproxil fumarateTestingUnited StatesVertebral columnVitamin DVitamin D DeficiencyWomanantiretroviral therapybasebonebone cellbone healthbone lossbone massbone strengthbone turnovercase controlcohortefavirenzemtricitabinehigh riskimmune functionimprovedindexingnew technologynovelosteoporosis with pathological fracturepublic health relevanceskeletal
项目摘要
DESCRIPTION (provided by applicant): Postmenopausal HIV+ women are at increased risk of fracture and vulnerable to adverse effects of D deficiency, HIV infection and ART-related bone loss on bone strength. The increasing prevalence of HIV-infection on older minority women and the aging of the HIV-infected population make it critical to elucidate the effects of HIV and its treatment on bone health.
描述(由申请人提供):绝经后HIV阳性妇女骨折的风险增加,容易受到D缺乏、HIV感染和art相关骨质流失对骨强度的不利影响。老年少数民族妇女中艾滋病毒感染率的上升和艾滋病毒感染人口的老龄化使得阐明艾滋病毒及其治疗对骨骼健康的影响至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth J Shane其他文献
Elizabeth J Shane的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth J Shane', 18)}}的其他基金
Phase 2b Study of Denosumab to Prevent Bone Loss in Idiopathic Osteoporosis in Premenopausal Women Treated with Teriparatide
狄诺塞麦 (Denosumab) 预防接受特立帕肽治疗的绝经前妇女特发性骨质疏松症骨丢失的 2b 期研究
- 批准号:
9282269 - 财政年份:2016
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8414605 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8717112 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8542495 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8020203 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8913676 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Phase 2 Teriparatide for Tx of Idiopathic Osteoporosis in Premenopausal Women
特立帕肽治疗绝经前女性特发性骨质疏松症的 2 期临床试验
- 批准号:
8333235 - 财政年份:2011
- 资助金额:
$ 67.75万 - 项目类别:
Osteoporosis in HIV Infected Postmenopausal Women
感染艾滋病毒的绝经后妇女的骨质疏松症
- 批准号:
8100411 - 财政年份:2010
- 资助金额:
$ 67.75万 - 项目类别:
Osteoporosis in HIV Infected Postmenopausal Women
感染艾滋病毒的绝经后妇女的骨质疏松症
- 批准号:
8011797 - 财政年份:2010
- 资助金额:
$ 67.75万 - 项目类别:
Osteoporosis in HIV Infected Postmenopausal Women
感染艾滋病毒的绝经后妇女的骨质疏松症
- 批准号:
8299138 - 财政年份:2010
- 资助金额:
$ 67.75万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 67.75万 - 项目类别:
Research Grant